CENTAUR PHARMACEUTICALS PVT LTD
CENTAUR PHARMACEUTICALS PVT LTD (India) holds 25 active US FDA Type II Drug Master Files and 2 inactive, has DMF or CEP filings on record for 30 active ingredients and is linked to 3 FDA-registered manufacturing sites. 4 FDA enforcement records are linked to it.
Sources: FDA Drug Master File list, EDQM certification database, FDA establishment registrations and enforcement records. How we read these records
Cite as: PharmaTek, “CENTAUR PHARMACEUTICALS PVT LTD: DMF, site and FDA enforcement record”, record as of 16 Nov 2026, pharmatek.co.uk/directory/centaur-pharmaceuticals-pvt-ltd
Overview
CENTAUR PHARMACEUTICALS PVT LTD is an active pharmaceutical ingredient (API) supplier with 34 active FDA Type II Drug Master Files, covering ALPRAZOLAM USP; AZITHROMYCIN DIHYDRATE USP; BRIMONIDINE TARTRATE USP; CHLORDIAZEPOXIDE HCL USP; CHLORDIAZEPOXIDE USP; CHLORZOXAZONE USP.
Core services & business areas
Active ingredients with DMF or CEP filings
Substances for which CENTAUR PHARMACEUTICALS PVT LTD holds, or has held, a US FDA Drug Master File or an EU CEP. A filing is not proof of current supply. Open any ingredient to see all its holders, CAS number and product patent dates.
API / Drug Master Files
CENTAUR PHARMACEUTICALS PVT LTD holds 25 active (27 total) FDA Type II Drug Master Files. A Type II DMF is filed with the FDA to support an active ingredient in drug applications; an active filing can be referenced but is not proof of current supply, and inactive filings are historical.
- LINAGLIPTINActive2022-05-30
- VARENICLINE TARTRATEActive2022-03-30
- FLUPHENAZINE HYDROCHLORIDE USPActive2021-09-23
- TRIAZOLAM USPActive2021-05-17
- CHLORDIAZEPOXIDE HCL USPActive2021-03-25
- CHLORZOXAZONE USPActive2017-09-29
- LEVOMILNACIPRAN HYDROCHLORIDEActive2017-04-28
- PINDOLOL USPActive2017-04-07
- ZOLPIDEM TARTRATE USPActive2016-08-12
- METOLAZONE USPActive2016-03-21
- LOXAPINE SUCCINATE USPActive2015-11-06
- CLOBAZAM USPActive2015-05-29
- ZALEPLON USPActive2013-09-25
- MILNACIPRAN HYDROCHLORIDEActive2012-12-03
- TETRABENAZINEActive2012-08-03
- ES-ZOPICLONE USPActive2012-06-07
- CHLORDIAZEPOXIDE USPActive2011-09-29
- BRIMONIDINE TARTRATE USPActive2010-06-09
- TIMOLOL MALEATE USPActive2010-03-11
- CLONAZEPAM USPActive2009-02-17
- LORAZEPAM USPActive2009-01-23
- OXAZEPAM USPActive2008-09-30
- DIAZEPAM USPActive2008-07-24
- ZOPICLONEActive2007-11-15
- ALPRAZOLAM USPActive2007-08-30
- NORTRIPTYLINE HCI USPInactive2011-10-07
- TEMAZEPAM USPInactive2011-10-03
Registered manufacturing sites (3)
Physical sites registered with the US FDA and resolved to CENTAUR PHARMACEUTICALS PVT LTD, with any EU/UK GMP documents matched to each site. Headquarters and manufacturing locations can differ.
FDA compliance signals
4 FDA enforcement records linked to this company.
- warning_letter2023-07-25
FDA Warning Letter (drug product)
- warning_letter2023-06-05
FDA Warning Letter (drug product)
- 4832016-11-14
Written program not followed
- 4832016-11-14
Establishment of time limitations
Is this CENTAUR PHARMACEUTICALS PVT LTD?
Send a link to a certificate, registration or filing we have missed or got wrong. We check it against the issuing register before changing anything; information we cannot check against a register is shown as supplier-reported.
Related companies
Need suppliers found and checked?
The Sourcing Desk turns these records into a checked shortlist: current filings, site, grade and regulatory history confirmed for your product, for a buyer-paid fixed fee and no supplier commission.